Neuralstem Inc is an biotechnology company which is engaged on developing and commercializing human neural stem cell technology in the emerging field of regenerative medicine.


Updates from The Motley Fool

Latest updates on Neuralstem from Fool.com.
3 Biotech Stocks to Buy in March

"Our life is March weather, savage and serene in one hour." --  Ralph Waldo Emerson Substitute "b...

Why Neuralstem Inc. Shares Soared

Although we don't believe in timing the market or panicking over market movements, we do like to ...

This Week in Biotech

With the SPDR S&P Biotech Index up 29% over the trailing 12-month period, it's evident that inv...

CAPScall of the Week: Neuralstem

For years, satirical late-night-TV host Stephen Colbert has been running a series on his show cal...

3 Stocks to Get on Your Watchlist

I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated. W...



Stock Performance

View Interactive CUR Charts
Sponsored by

Key Data Points

Primary metrics and data points about Neuralstem.
Current Price: $0.26
Prev Close: $0.26
Open: $0.25
Bid: $0.25
Ask: $0.27
Day's Range: $0.25 - $0.27
52wk Range: $0.19 - $1.20
Volume: 211,093
Avg Vol 326,914
Market Cap: $24M
P/E (ttm): -1.27
EPS (ttm): ($0.20)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Neuralstem.
CAPS Rating 3 out of 5
 
85 Outperform
11 Underperform
CAPS All Stars
 
10 Outperform
3 Underperform

How do you think Neuralstem will perform against the market?



You pick for Neuralstem is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Neuralstem.

Neuralstem Inc is an biotechnology company which is engaged on developing and commercializing human neural stem cell technology in the emerging field of regenerative medicine.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers